Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-Up Study on Medical Devices KalobaNaso Useful for Cold and Rhinitis in Adults and Children

NCT05960318 is registered in ClinicalTrials.gov with Schwabe Pharma Italia as lead sponsor.

NCT NCT05960318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05960318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-Up Study on Medical Devices KalobaNaso Useful for Cold and Rhinitis in Adults and Children
Lead sponsor
Schwabe Pharma Italia
Phase
Observational
Overall status
Completed
Start date
May 8, 2023
Completion date
July 31, 2023
Enrollment
131 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common cold, nasal mucosal inflammation, rhinitis